A detailed history of Amalgamated Bank transactions in Tenaya Therapeutics, Inc. stock. As of the latest transaction made, Amalgamated Bank holds 1,587 shares of TNYA stock, worth $2,650. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,587
Previous 1,587 -0.0%
Holding current value
$2,650
Previous $5,000 40.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$2.72 - $4.99 $1,653 - $3,033
608 Added 62.1%
1,587 $5,000
Q1 2024

Apr 23, 2024

SELL
$2.88 - $6.8 $7,286 - $17,204
-2,530 Reduced 72.1%
979 $5,000
Q4 2023

Feb 06, 2024

SELL
$1.73 - $3.39 $503 - $986
-291 Reduced 7.66%
3,509 $11,000
Q1 2023

May 02, 2023

BUY
$1.92 - $3.59 $478 - $893
249 Added 7.01%
3,800 $11,000
Q2 2022

Aug 15, 2022

BUY
$5.01 - $14.12 $5,400 - $15,221
1,078 Added 43.59%
3,551 $20,000
Q1 2022

Jun 30, 2022

BUY
$9.41 - $19.3 $23,270 - $47,728
2,473 New
2,473 $29,000

Others Institutions Holding TNYA

About Tenaya Therapeutics, Inc.


  • Ticker TNYA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,364,700
  • Market Cap $69.1M
  • Description
  • Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through cellular regeneration, gene therapy, and precision medicine platforms. The company is developing TN-201, an adeno-associated virus (AAV)-based gene therapy to address genetic hyp...
More about TNYA
Track This Portfolio

Track Amalgamated Bank Portfolio

Follow Amalgamated Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.